[HTML][HTML] Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives
M Alhenc‐Gelas, G Plu‐Bureau, S Guillonneau… - Journal of thrombosis …, 2004 - Elsevier
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …
thromboembolism. Previous data reported higher thrombotic risk in women using third …
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives
M Alhenc‐Gelas, G Plu‐Bureau… - … of Thrombosis and …, 2004 - Wiley Online Library
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …
thromboembolism. Previous data reported higher thrombotic risk in women using third …
[PDF][PDF] Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives
PY SCARABIN - Journal of Thrombosis and Haemostasis, 2004 - ipc.asso.fr
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using …
thromboembolism. Previous data reported higher thrombotic risk in women using …
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives
M Alhenc-Gelas, G Plu-Bureau… - … of thrombosis and …, 2004 - pubmed.ncbi.nlm.nih.gov
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …
thromboembolism. Previous data reported higher thrombotic risk in women using third …
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives.
M Alhenc-Gelas, G Plu-Bureau… - … of Thrombosis and …, 2004 - europepmc.org
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …
thromboembolism. Previous data reported higher thrombotic risk in women using third …
[HTML][HTML] Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives
M Alhenc‐Gelas, G Plu‐Bureau… - Journal of Thrombosis …, 2004 - jthjournal.org
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …
thromboembolism. Previous data reported higher thrombotic risk in women using third …